AU2002217102A1 - Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins - Google Patents

Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins

Info

Publication number
AU2002217102A1
AU2002217102A1 AU2002217102A AU1710202A AU2002217102A1 AU 2002217102 A1 AU2002217102 A1 AU 2002217102A1 AU 2002217102 A AU2002217102 A AU 2002217102A AU 1710202 A AU1710202 A AU 1710202A AU 2002217102 A1 AU2002217102 A1 AU 2002217102A1
Authority
AU
Australia
Prior art keywords
colloids
biocompatible
cell adhesion
reduced cell
blood proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217102A
Inventor
Horst Hermel
Kaspar Matiasek
Helmuth Mohwald
Hubert Motschmann
Wolfgang Schmahl
Claudia Sperling
Andreas Thunemann
Euridice Vieira
Carsten Werner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of AU2002217102A1 publication Critical patent/AU2002217102A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/068—Use of macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/02—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to biocompatible colloids, which can be used particularly in biological and medical applications. The colloids can be used, particularly: a) for reducing cell adhesion on medical products and/or b) for reducing pathogenic deposits (plaques), such as amyloid deposits.
AU2002217102A 2000-12-11 2001-12-11 Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins Abandoned AU2002217102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10061573A DE10061573A1 (en) 2000-12-11 2000-12-11 Biocompatible colloids with low cell adhesion and active stabilization of blood proteins
DE10061573.2 2000-12-11
PCT/EP2001/014542 WO2002047738A2 (en) 2000-12-11 2001-12-11 Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins

Publications (1)

Publication Number Publication Date
AU2002217102A1 true AU2002217102A1 (en) 2002-06-24

Family

ID=7666628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217102A Abandoned AU2002217102A1 (en) 2000-12-11 2001-12-11 Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins

Country Status (5)

Country Link
EP (1) EP1341564B1 (en)
AT (1) ATE275984T1 (en)
AU (1) AU2002217102A1 (en)
DE (2) DE10061573A1 (en)
WO (1) WO2002047738A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004040119A1 (en) * 2004-08-18 2006-04-27 Heinrich-Heine-Universität Düsseldorf Agent, useful for e.g. inactivating infectious prion and decontaminating device, instrument or appliance infected with prion, comprises a nano-particle

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231787T2 (en) * 1991-01-28 2001-08-02 Matsushita Electric Ind Co Ltd Medical article and process for its manufacture
DE19718200A1 (en) * 1996-11-06 1998-05-07 Bayer Ag Thermoplastic polysaccharide salts
WO1999024513A1 (en) * 1997-11-06 1999-05-20 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Self-arranging coating
US6248127B1 (en) * 1998-08-21 2001-06-19 Medtronic Ave, Inc. Thromboresistant coated medical device
DE19913579A1 (en) * 1999-03-24 2000-09-28 Colloid Surface Technologies G Oil- and water-repellent and antifouling coating composition, comprises a complex of polyelectrolyte ions and fluorosurfactant counterions and a crosslinker

Also Published As

Publication number Publication date
DE10061573A1 (en) 2002-09-26
EP1341564B1 (en) 2004-09-15
DE50103679D1 (en) 2004-10-21
WO2002047738A3 (en) 2002-08-22
WO2002047738A2 (en) 2002-06-20
EP1341564A2 (en) 2003-09-10
ATE275984T1 (en) 2004-10-15

Similar Documents

Publication Publication Date Title
GB9902652D0 (en) Process
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
NO20023846D0 (en) Antiadhesive carbohydrates
DE59410052D1 (en) USE OF NONA AND DECAPEPTIDES FOR THE PRODUCTION OF A MEDICINAL AGAINST AIDS
TW200806317A (en) Methods for reducing protein aggregation
AP1763A (en) Pulmonary administration of chemically modified insulin
MXPA03005273A (en) Prokaryotically produced antibodies and uses thereof.
AU1685499A (en) Polypeptide, their production and use
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
WO2004091497A3 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
AU4073901A (en) Novel pharmaceutical or dietetic mushroom-based compositions
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2002317501A1 (en) Antiobestic and/or antidiabetic agent containing cyanidin 3-glucoside as active ingredient
MXPA04005346A (en) Use of micro-organisms for a directed delivery of substances to specific parts of the gut.
AU2001267561A1 (en) Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents
AU4414400A (en) Lactic acid bacteria with anxiolytic properties and uses thereof
AU2002217102A1 (en) Biocompatible colloids with reduced cell adhesion and active stabilisation of blood proteins
ATE353642T1 (en) USE OF HYPOESTOXIDES AS ANTIPARASITIVE AGENTS
AU2525601A (en) Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof
SE0203671D0 (en) Method of preparing a medical solution
MXPA02003731A (en) Novel fusidic acid derivatives.
WO2001045743A3 (en) Use of an enzyme to improve the resorption of medicaments in the tissue
AU6290398A (en) Inclusion complexes in aqueous solution
SE0203672D0 (en) Method of preparing a medical solution
BG104385A (en) Physiologically acceptable aqueous solutions and methods for their application